Company / Assets per Share
Dexcom Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$16.48
FY2025
5-year range
$13.90 / $51.34
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
#114 of 158
Health Care
What the data says
At $16.48, Dexcom's assets per share ranks #114 of 158 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $4.93 in FY2016 to $51.34 in FY2021.
Based on SEC 10-K filings.
16.48 in FY2025 with a 5-year CAGR of -18.1%.
Remained stable around $16.48 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +5.8%
- 5-Year CAGR
- -18.1%
- 10-Year CAGR
- -
Sector benchmark
#114 of 158 in Health CareTop 72% of 158This company $16.48 Sector average $117.21
▼
-85.9% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 0.7% year-over-year.
- Ranks #114 out of 158 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.48 | -0.7% |
| FY2024 | $16.60 | +2.1% |
| FY2023 | $16.25 | +17.0% |
| FY2022 | $13.90 | -72.9% |
| FY2021 | $51.34 | +15.0% |
| FY2020 | $44.65 | +70.8% |
| FY2019 | $26.15 | +18.7% |
| FY2018 | $22.02 | +106.1% |
| FY2017 | $10.69 | +116.8% |
| FY2016 | $4.93 | +30.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026